Conferences
BIO International Convention 2025
Conference Name: BIO International Convention 2025
Time: June 16-19, 2025
Location: Boston Convention & Exhibition Center
Axcelead Drug Discovery Partner, Inc. and ARCALIS, Inc., group companies of Axcelead, Inc., will be attending BIO International Convention 2025 in Boston, MA, USA. Visit us at Booth #3278 to learn how we can empower your drug discovery. Let’s connect in the partneringOne system to discuss more details. Our team looks forward to meeting you there!
Yoshinori Ikeura, PhD
Board Director, Co-CEO and CTO, Axcelead, Inc. / Board Chairperson, Axcelead Drug Discovery Partners, Inc.
- Former Head of Shonan research center, Takeda Pharmaceutical Company
- Former Chairman of Japan Pharmaceutical Manufacturers Association R&D committee
- Former Board member of Japan Bioindustry Association
- RSC, Med.Chem.Comm. editorial board
- >30 years of experience in Drug discovery（>5 IND)
- >15 publication, >15 patent
Masayuki Ii, PhD
CSO, Axcelead Drug Discovery Partners, Inc.
- Former Head of inflammation DDU, Takeda Pharmaceutical Company
- >25 years of experience in drug discovery and development, lead of research in global development programs
- >20 publicastions, >40 patents
Kazuyoshi Aso, PhD
Head, Global Business Development, Axcelead Drug Discovery Partners, Inc.
- Former VP, Head of Chemistry, Axcelead DDP
- Former VP, Head of Medicinal Chemistry, Tri-I TDI
- >5 years of experience in global business development
- >30 years of experience in drug discovery research
- >30 publications, >20 patents
Belinda Deng
Global Business Development, Axcelead Drug Discovery Partners, Inc.
- >10 years of experience in B2B marketing at global and Japanese companies, including Edwards, Stanley Black & Decker and Imada
- >5 years of experience in global sales and marketing
- 2 years of experience in global business development in the healthcare industry
Satoshi Takamatsu, PhD
Corporate Officer, CDMO Business Supervisor, Axcelead, Inc. / Representative Director, President and CEO, ARCALIS, Inc.
- >30 years of experience in life sciences and CDMO business operation in companies such as Ajinomoto, Fujifilm, and AGC
- >50 cases of experience in M&A transactions in the life sciences and CDMO industries, with a total deal size of over 1 trillion yen
- >30 cases of experience in pharmaceutical licensing-in and licensing-out activities
- >15 publications, >20 patents in the field of pharmaceutical development and production
Yuki Hasegawa, PhD
Vice Chairperson, Business Development General Manager, ARCALIS, Inc./ Healthcare Investment Head, Whiz Partners, Inc
- >10 years of experience in genomic/transcriptome/stem cell research in Academia and experience in regenerative medicine business in Asahi Kasei
- >5 years of experience in business development
- >5 years of experience in investment and hands-on support in healthcare
- >20 publications in genomics and transcriptomics
Hamid Trimech
Business Development Manager, ARCALIS Inc
- Engineer, with a decade of experience in vaccine manufacturing and technology transfer
- Involved in the manufacturing projects on more than 15 different vaccines in France, South Korea, Japan, India, Brazil, Argentina and Mexico.
- 6 vaccines modalities, including attenuated, inactivated, subunit, recombinant protein, conjugated, and mRNA vaccines.
- Delivered 2 approved COVID-19 vaccines (protein / mRNA)
- Former Process Engineer at Sanofi Pasteur Global Engineering Department in charge of drug substance manufacturing projects in South America and Asia.